Interview with Syngene at CPHI in Frankfurt, Germany

KEY LEARNING OBJECTIVES

• Syngene is an end-to-end CRO/CDMO which offers standalone as well as integrated services for small molecules and biologics
• We not only have capabilities but also capacity to fulfil commercial manufacturing requirements
• We can be a innovation partner for niche areas as well as small biotech/pharma companies